T3011 oncolytic virus (OV) in patients with solid tumors
People with Metastatic Solid Tumors are asked to participate in a research study being conducted by Montefiore Medical Center.
You may be eligible to participate in this study if you:
- Are a male or female at least 18 years of age
- Have disease progression after SOC therapy
- Have adequate hepatic & renal function
You may NOT participate in this study if you:
- Have prior treatment with another OV or cellular therapy
- Have untreated and/or symptomatic metastatic central nervous system (CNS) disease
- Have splenectomy, previous allogenic tissue/solid organ transplant
- Have known immunodeficiency virus (HIV) infection, hepatitis B or C
- Have live vaccines within 4 weeks of initiation of study treatment. (Seasonal flu or
- SARS-CoV-2 vaccines that do not contain live viruses are permitted.)
- Are pregnant or breastfeeding
Contact Information
Mohammad Ghalib, Research Manager
1695 Eastchester Road, 2nd floor
Bronx, NY 10461
Phone: (718) 405-8515
Email: mhghalib@montefiore.org